Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

MNST

Monster Beverage Corp.

May 03 • 04:00PM ET

55.00

Dollar change +1.61
Percentage change 3.02	%

Consumer Defensive • Beverages - Non-Alcoholic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ VUG IVV JEPI FTCS VDC IWF QUAL

Index	NDX, S&P 500	P/E	34.67	EPS (ttm)	1.59	Insider Own	27.33%	Shs Outstand	1.04B	Perf Week	3.05%
Market Cap	57.24B	Forward P/E	26.91	EPS next Y	2.04	Insider Trans	-0.26%	Shs Float	756.25M	Perf Month	-1.35%
Income	1.68B	PEG	2.68	EPS next Q	0.46	Inst Own	66.01%	Short Float	1.61%	Perf Quarter	-0.63%
Sales	7.34B	P/S	7.80	EPS this Y	16.31%	Inst Trans	0.70%	Short Ratio	2.30	Perf Half Y	6.49%
Book/sh	8.23	P/B	6.68	EPS next Y	14.12%	ROA	17.69%	Short Interest	12.20M	Perf Year	-5.76%
Cash/sh	3.42	P/C	16.07	EPS next 5Y	12.95%	ROE	20.98%	52W Range	47.13 - 61.22	Perf YTD	-4.53%
Dividend Est.	-	P/FCF	38.25	EPS past 5Y	11.87%	ROI	20.24%	52W High	-10.17%	Beta	0.77
Dividend TTM	-	Quick Ratio	4.15	Sales past 5Y	13.47%	Gross Margin	54.17%	52W Low	16.70%	ATR (14)	1.16
Dividend Ex-Date	-	Current Ratio	4.91	EPS Y/Y TTM	30.09%	Oper. Margin	27.51%	RSI (14)	50.58	Volatility	2.19% 2.00%
Employees	6003	Debt/Eq	0.01	Sales Y/Y TTM	13.08%	Profit Margin	22.83%	Recom	2.04	Target Price	62.76
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	11.91%	Payout	0.00%	Rel Volume	2.27	Prev Close	53.39
Sales Surprise	-0.02%	EPS Surprise	-3.40%	Sales Q/Q	11.78%	Earnings	May 02 AMC	Avg Volume	5.30M	Price	55.00
SMA20	1.46%	SMA50	-3.10%	SMA200	-1.27%	Trades		Volume	12,058,291	Change	3.02%

Date	Action	Analyst	Rating Change	Price Target Change
May-03-24	Reiterated	UBS	Neutral	$61 → $60
May-03-24	Reiterated	Piper Sandler	Neutral	$58 → $59
May-03-24	Reiterated	Morgan Stanley	Overweight	$68 → $65
May-03-24	Reiterated	BMO Capital Markets	Market Perform	$58 → $56
Apr-25-24	Downgrade	Truist	Buy → Sell	$65 → $46
Apr-25-24	Downgrade	JP Morgan	Overweight → Neutral	$66 → $59
Mar-06-24	Initiated	Redburn Atlantic	Buy
Feb-29-24	Reiterated	UBS	Neutral	$62 → $63
Feb-29-24	Reiterated	RBC Capital Mkts	Outperform	$60 → $65
Feb-29-24	Reiterated	Morgan Stanley	Overweight	$63 → $68
Feb-29-24	Reiterated	Jefferies	Buy	$66 → $69
Feb-29-24	Reiterated	Deutsche Bank	Buy	$63 → $66
Feb-26-24	Reiterated	Deutsche Bank	Buy	$64 → $63
Jan-17-24	Reiterated	JP Morgan	Overweight	$61 → $65
Jan-17-24	Reiterated	Goldman	Buy	$62 → $68
Jan-17-24	Reiterated	Citigroup	Buy	$63 → $69
Jan-17-24	Reiterated	BMO Capital Markets	Market Perform	$57 → $58
Nov-20-23	Reiterated	ROTH MKM	Neutral	$57 → $55
Nov-20-23	Reiterated	Piper Sandler	Neutral	$50 → $58
Nov-13-23	Initiated	Jefferies	Buy	$65

Show Previous Ratings

May-04-24 07:38AM	23 Most Profitable Stocks of the Last 12 Months (Insider Monkey)
May-03-24 01:52PM	Monster Beverage's (MNST) Q1 Earnings Miss, Sales Rise Y/Y (Zacks)
01:25PM	Analyst Report: Monster Beverage Corporation (Morningstar Research)
01:04PM	Monster Beverage Corporation (NASDAQ:MNST) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:50AM	UBS Adjusts Price Target on Monster Beverage to $60 From $61, Maintains Neutral Rating (MT Newswires)
08:31AM	Loading…
08:31AM	Q1 2024 Monster Beverage Corp Earnings Call (Thomson Reuters StreetEvents)
08:23AM	Monster Beverage co-CEO plans to step back next year (Just Drinks)
06:35AM	Morgan Stanley Adjusts Price Target on Monster Beverage to $65 From $68 (MT Newswires)
06:02AM	BMO Capital Adjusts Price Target on Monster Beverage to $56 From $58 (MT Newswires)
May-02-24 08:56PM	MNST Stock Earnings: Monster Beverage Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:24PM	Monster Beverage posts higher Q1 revenue on resilient demand, easing costs (Reuters)
05:32PM	Monster Beverage Corp (MNST) Q1 2024 Earnings: Aligns with EPS Projections Amidst Robust Sales ... (GuruFocus.com)
04:59PM	Monster (NASDAQ:MNST) Reports Q1 In Line With Expectations (StockStory)
04:58PM	Monster Beverage: Q1 Earnings Snapshot (Associated Press Finance)
04:04PM	Monster Beverage Reports 2024 First Quarter Results (GlobeNewswire)
12:03PM	Loading…
May-01-24 12:03PM	Will Energy Drinks Aid Monster Beverage's (MNST) Q1 Earnings? (Zacks)
12:01PM	Monster Beverage Faces Strong Long-term Growth Potential Despite Current Hurdles, RBC Says (MT Newswires)
03:13AM	Monster (MNST) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-30-24 07:29AM	Jim Cramer is Recommending These 10 Stocks Heading Into May 2024 (Insider Monkey)
Apr-29-24 04:46PM	7 Diamond-in-the-Rough Stocks Worth Digging Up Now (InvestorPlace)
Apr-26-24 08:00AM	Monster Beverage to Report Financial Results for 2024 First Quarter on May 2, 2024 (GlobeNewswire)
Apr-25-24 11:32AM	Monster Beverage Stock Was Once a Big Winner. Why It Just Got 2 Downgrades. (Barrons.com)
10:02AM	Monster Beverage (MNST) Earnings Expected to Grow: Should You Buy? (Zacks)
09:44AM	Monster downgraded, Five Below upgraded: Wall Street's top analyst calls (The Fly)
Apr-24-24 12:41PM	Monster Beverage's (MNST) Growth Strategies Good: Apt to Hold (Zacks)
Apr-23-24 11:37AM	--Bernstein Adjusts Price Target on Monster Beverage to $63 From $66 (MT Newswires)
Apr-17-24 06:10AM	Take a Pass! The Monster Rally in Monster Stock Will End Soon. (InvestorPlace)
Apr-16-24 08:30AM	Monster Energy Cares: Rob Gronkowski on Life After Football and Gronk Nation Youth Foundation (ACCESSWIRE)
03:19AM	10 Best Beverage Dividend Stocks To Buy Now (Insider Monkey)
Apr-15-24 09:19AM	The Monster That Turned $1 Into $20,000: Why This Energy Drink Stock Is a Must-Buy (InvestorPlace)
11:25AM	Loading…
Apr-12-24 11:25AM	Monster Energy "Beat The Beast" Call of Duty Tournament Donates $100k to Charity (ACCESSWIRE)
Apr-11-24 09:11AM	3 Fantastic Growth Stocks That Have Turned $10,000 Into $3 Million in 20 Years (Motley Fool)
04:45AM	Beverages and Alcohol Stocks Q4 Results: Benchmarking Monster (NASDAQ:MNST) (StockStory)
Apr-10-24 01:05PM	3 Dull but Dependable Stocks to Buy as Inflation Fears Continue (InvestorPlace)
Apr-04-24 06:15PM	Monster Beverage (MNST) Stock Moves -0.36%: What You Should Know (Zacks)
10:50AM	Monster Beverage's (MNST) Expansion Strategy Bodes Well (Zacks)
Apr-03-24 10:16AM	This Monster Growth Stock Is Up 5,730% in the Last 5 Years (Motley Fool)
09:14AM	7 Nasdaq Stocks to Sell in April Before They Crash & Burn (InvestorPlace)
Mar-31-24 10:34PM	15 Top Selling Energy Drink Brands in the US (Insider Monkey)
04:10AM	Celsius Is Now a Billion-Dollar Business in North America After Doubling in 2023. That's Why It's Looking for Growth in These 5 International Markets in 2024 and Beyond. (Motley Fool)
Mar-30-24 11:16AM	It's Not Impossible for Nvidia Stock to Hit $10,000 by 2025 (InvestorPlace)
Mar-29-24 11:30AM	Why Is Monster Beverage (MNST) Up 0.3% Since Last Earnings Report? (Zacks)
03:41AM	5 Most Valuable Alcohol Companies in the World (Insider Monkey)
Mar-28-24 10:41AM	Can Celsius Stock Energize Your Portfolio? (Motley Fool)
Mar-27-24 06:15PM	Monster Beverage (MNST) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
10:43AM	14 Best Defensive ETFs To Buy For Plunging Markets (Insider Monkey)
09:15AM	Monster Energy Cares: Meet Roy Tuscany, Founder of the High Fives Foundation (ACCESSWIRE)
Mar-25-24 08:15AM	Monster Beverage Corporation's Commitment to Water Stewardship (ACCESSWIRE)
Mar-23-24 07:37AM	Is It Too Late to Buy Coca-Cola Stock? (Motley Fool)
Mar-20-24 06:15PM	Monster Beverage (MNST) Stock Dips While Market Gains: Key Facts (Zacks)
Mar-19-24 02:37PM	Where Will Celsius Holdings Stock Be in 10 Years? (Motley Fool)
Mar-14-24 06:15PM	Monster Beverage (MNST) Dips More Than Broader Market: What You Should Know (Zacks)
Mar-12-24 12:17AM	Analyst Report: Monster Beverage Corporation (Morningstar Research)
Mar-11-24 12:48PM	Monster Beverage's (MNST) Growth Strategies Progress Well (Zacks)
12:26PM	Shorting the Shorts: 3 Stocks Primed for an Epic Squeeze (InvestorPlace)
Mar-09-24 09:38AM	Alternatives to Celsius Drink: 10 Best Energy Drinks (Insider Monkey)
Mar-08-24 06:00PM	Monster Beverage (MNST) Stock Moves -0.34%: What You Should Know (Zacks)
04:16PM	Energy-Drink Maker Celsiuss Record Run Stings Short Sellers (Bloomberg)
Mar-06-24 02:02AM	What To Expect From Duckhorns (NAPA) Q2 Earnings (StockStory)
Mar-05-24 02:00PM	Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio (InvestorPlace)
08:00AM	Celsius Holdings Has Upside Potential Following Meteoric Share Price Rise (GuruFocus.com)
Mar-04-24 11:18AM	1 Skyrocketing Stock That Crushed the "Magnificent Seven" in the Last 5 Years (Motley Fool)
Mar-02-24 07:11AM	2 Energy Drink Stocks to Buy Hand Over Fist in March (Motley Fool)
Mar-01-24 01:10AM	MNST, STZ, COCO: Cheers! 3 Analyst-Approved Beverage Stocks (TipRanks)
12:01AM	Decoding Monster Beverage Corp (MNST): A Strategic SWOT Insight (GuruFocus.com)
Feb-29-24 04:25PM	Celsius Spikes On Earnings; Is It Getting A Wall Street Bets Boost? (Investor's Business Daily) +5.82%
03:45PM	Why Monster Beverage Stock Jumped on Thursday (Motley Fool)
01:43PM	Top Stock Movers Now: Hormel, Bath & Body Works, Best Buy, and More (Investopedia)
12:34PM	Monster Beverage (MNST) Q4 Earnings Miss, Sales Rise Y/Y (Zacks)
10:11AM	Monster Beverage Corporation (NASDAQ:MNST) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:56AM	Celsius Swings To Profit, Breaks Out; Monster Beverage Rallies (Investor's Business Daily)
08:46AM	Analyst Report: Monster Beverage Corporation (Morningstar Research)
06:53AM	Q4 2023 Monster Beverage Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 11:11PM	CORRECTION Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results (GlobeNewswire)
06:10PM	UPDATE 1-Monster Beverage misses revenue estimates as higher prices pinch demand (Reuters)
04:52PM	Monster Beverage Corp (MNST) Delivers Strong Q4 and Full-Year 2023 Results (GuruFocus.com)
04:49PM	Monster Beverage misses revenue estimates as higher prices pinch demand (Reuters)
04:35PM	Monster Beverage: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	Monster (NASDAQ:MNST) Misses Q4 Sales Targets (StockStory)
04:10PM	Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results (GlobeNewswire)
Feb-27-24 02:01AM	Monster (MNST) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-24-24 12:32PM	Why I Bought Celsius Holdings Stock (Motley Fool)
06:45AM	Is It Too Late to Buy Celsius Holdings Stock? (Motley Fool)
Feb-23-24 09:15AM	Seeking Clues to Monster Beverage (MNST) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-22-24 12:03PM	3 Stand-Strong Stocks to Buy as Inflation Concerns Fester (InvestorPlace)
07:17AM	Monster Beverage (MNST) Looks Poised for Earnings Beat in Q4 (Zacks)
06:19AM	ROIC Rockstars: 3 Stocks to Buy for Long-Term Rewards (InvestorPlace)
03:15AM	10 Fastest Growing Energy Drink Stocks in the US (Insider Monkey)
Feb-21-24 04:00PM	Monster Beverage to Report Financial Results for 2023 Fourth Quarter on February 28, 2024 (GlobeNewswire)
09:27AM	1 Growth Stock Down 28% to Buy Right Now (Motley Fool)
Feb-20-24 06:00PM	Monster Beverage (MNST) Advances While Market Declines: Some Information for Investors (Zacks)
10:00AM	Monster Beverage (MNST) Earnings Expected to Grow: What to Know Ahead of Q4 Release (Zacks)
Feb-12-24 06:00PM	Monster Beverage (MNST) Gains As Market Dips: What You Should Know (Zacks)
03:29PM	The Next Coca-Cola? 3 Beverage Stocks That Investors Shouldnt Ignore. (InvestorPlace)
05:06AM	Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names (Motley Fool)
Feb-07-24 08:45AM	Sports Nutrition Market Size Expected to Reach $81 Billion by 2030 as Workout Nutritional Supplements Demand Rises (GlobeNewswire)
Feb-06-24 11:02PM	Celsius Stock (NASDAQ:CELH): How Promising Is Its International Expansion? (TipRanks)
07:40AM	Monster Beverage (MNST) to Benefit From Energy Drinks Business (Zacks)
Feb-05-24 06:00PM	Why Monster Beverage (MNST) Dipped More Than Broader Market Today (Zacks)
05:16PM	High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year (InvestorPlace)

Monster Beverage Corp. is a holding company, which engages in the development, marketing, sale, and distribution of energy drink beverages and concentrates. It operates through the following segments: Monster Energy Drinks, Strategic Brands, and Other. The Monster Energy Drinks segment sells ready-to-drink packaged energy drinks to bottlers and full-service beverage distributors. The Strategic Brands segment sells concentrates and beverage bases to authorized bottling and canning operations. The Other segment consists of certain products sold by its subsidiary, American Fruits and Flavors LLC to independent third-party customers. The company was founded on April 25, 1990, and is headquartered in Corona, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HALL MARK J	Director	Mar 04 '24	Option Exercise	25.76	409,000	10,535,420	1,436,840	Mar 06 06:38 PM
HALL MARK J	Director	Mar 04 '24	Sale	58.55	659,000	38,584,450	777,840	Mar 06 06:38 PM
SACKS RODNEY C	Chairman and Co-CEO	Dec 27 '23	Option Exercise	14.66	3,444,420	50,493,655	1,680,000	Dec 29 05:58 PM
SCHLOSBERG HILTON H	Vice Chairman and Co-CEO	Dec 27 '23	Option Exercise	14.66	3,444,420	50,493,655	1,680,000	Dec 29 06:00 PM
SCHLOSBERG HILTON H	Vice Chairman and Co-CEO	Dec 27 '23	Option Exercise	11.68	8,562	100,004	1,959,613	Dec 29 06:00 PM
SACKS RODNEY C	Chairman and Co-CEO	Dec 27 '23	Option Exercise	11.68	8,562	100,004	956,466	Dec 29 05:58 PM
Carling Guy	President of EMEA	Dec 14 '23	Option Exercise	25.75	16,660	428,995	34,553	Dec 15 07:31 PM
Tirre Emelie	President of the Americas	Dec 14 '23	Option Exercise	29.37	3,404	99,975	60,413	Dec 15 07:29 PM
Carling Guy	President of EMEA	Dec 14 '23	Sale	55.55	34,553	1,919,419	0	Dec 15 07:31 PM
KELLY THOMAS J	Chief Financial Officer	Nov 22 '23	Option Exercise	28.48	30,000	854,300	90,056	Nov 27 05:16 PM
KELLY THOMAS J	Chief Financial Officer	Nov 22 '23	Sale	55.19	30,000	1,655,700	60,056	Nov 27 05:16 PM
VIDERGAUZ MARK	Director	Nov 22 '23	Sale	55.39	2,000	110,780	79,270	Nov 22 05:39 PM
VIDERGAUZ MARK	Director	Nov 20 '23	Sale	54.90	3,000	164,700	81,270	Nov 22 05:39 PM
Demel Ana	Director	Aug 21 '23	Sale	57.24	116	6,640	0	Aug 23 04:24 PM
HALL MARK J	Director	Aug 14 '23	Sale	58.81	56,202	3,305,240	1,027,840	Aug 16 06:17 PM
VIDERGAUZ MARK	Director	Aug 14 '23	Sale	59.00	5,000	295,000	84,270	Aug 16 06:16 PM
HALL MARK J	Director	Aug 10 '23	Sale	58.64	57,220	3,355,381	1,084,042	Aug 11 07:33 PM
HALL MARK J	Director	Aug 09 '23	Sale	57.35	110,000	6,308,500	1,141,262	Aug 11 07:33 PM
VIDERGAUZ MARK	Director	May 22 '23	Sale	59.75	4,000	239,000	89,270	May 24 06:20 PM
KELLY THOMAS J	Chief Financial Officer	May 12 '23	Option Exercise	29.37	93,192	2,737,049	153,248	May 16 05:01 PM
KELLY THOMAS J	Chief Financial Officer	May 12 '23	Sale	59.41	93,192	5,536,537	60,056	May 16 05:01 PM
VIDERGAUZ MARK	Director	May 11 '23	Sale	59.13	4,000	236,520	93,270	May 15 05:11 PM
Tirre Emelie	President of the Americas	May 10 '23	Option Exercise	28.44	129,930	3,695,375	183,914	May 12 07:16 PM
Tirre Emelie	President of the Americas	May 10 '23	Sale	59.15	129,930	7,685,360	53,984	May 12 07:16 PM
Carling Guy	President of EMEA	May 09 '23	Option Exercise	31.52	60,100	1,894,502	95,364	May 11 05:11 PM
Carling Guy	President of EMEA	May 09 '23	Sale	58.74	80,591	4,733,915	14,773	May 11 05:11 PM

Open in Screener

PJP

Invesco Pharmaceuticals ETF

May 03 • 04:00PM ET

79.21

Dollar change +0.57
Percentage change 0.72	%

Financial • Exchange Traded Fund • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	3.83%	Shs Outstand		Perf Week	3.68%
Sponsor	Invesco	ETF Type		Tags	equity	Return% 3Y	1.03%	Total Holdings	24	Perf Month	1.67%
Fund Family		Bond Type		Tags	pharmaceutical	Return% 5Y	5.60%	AUM	268.35M	Perf Quarter	4.29%
Index	Dynamic Pharmaceuticals Intellidex Indx	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	13.81%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	2.83%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-4.68%	52W Range	67.75 - 80.65	Perf YTD	4.09%
Dividend TTM	0.74 (0.93%)	ESG Type		Tags	-	Flows% 3M	-5.49%	52W High	-1.79%	Beta	0.59
Dividend Ex-Date	Mar 18, 2024	Dividend Type		Sector/Theme		Flows% YTD	-1.78%	52W Low	16.91%	ATR (14)	0.92
Expense	0.57%	Structure Type		Region		Flows% 1Y		RSI (14)	62.22	Volatility	1.36% 1.02%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.37	Prev Close	78.64
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	24.74K	Price	79.21
SMA20	2.98%	SMA50	1.68%	SMA200	4.98%	Trades		Volume	9,099	Change	0.72%

Mar-09-23 12:00PM	Biden targets crypto, real estate and oil industries, as he unveils his budget (MarketWatch)
Dec-28-22 03:30PM	Subversive Launches ETF to Focus on Mental Health (ETF.com)
Sep-20-22 03:13PM	Best Pharmaceutical ETFs for Q4 2022 (Investopedia)
Aug-02-21 06:18PM	Eli Lilly (LLY) Option Traders Prepped for Earnings Beat (Investopedia)
05:21PM	Amgen (AMGN) Option Traders Unenthusiastic Into Earnings (Investopedia)
04:14PM	Loading…
Oct-30-20 04:14PM	Heres where Trump and Biden stand on COVID-19, other health-care issues (MarketWatch)
Aug-07-20 12:35PM	Trumps Buy American order on essential drugs looks toothless, analysts say (MarketWatch)
Jul-31-20 02:17PM	Dont buy health-care stocks if Democrats sweep the November elections, these contrarian analysts say (MarketWatch)
Jul-28-20 12:00PM	Trumps meeting with pharma execs called off, as analysts say his moves on drug prices lack bite (MarketWatch)
Jul-24-20 04:10PM	Pharma stocks fall as Trump targets drug prices with executive orders (MarketWatch)
Jun-04-20 01:00PM	5 Sector ETFs Just Got Upgraded to Buy (Zacks)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Feb-06-20 01:10PM	Trump rips very unfair impeachment effort as he celebrates acquittal at White House (MarketWatch)
Feb-05-20 05:03PM	Trump acquitted by Senate, ending historic impeachment trial (MarketWatch)
10:50AM	Trumps State of the Union speech: Investors in drug makers should be relieved, analyst says (MarketWatch)
02:51PM	Loading…
Feb-04-20 02:51PM	Democratic caucus goers in Iowa focused most on health care, followed by climate change (MarketWatch)
Dec-20-19 08:10AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-12-19 02:34PM	Pelosis drug-pricing bill passes House, but pharma stocks are up as its unlikely to become law (MarketWatch)
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Oct-15-19 11:53AM	Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts (InvestorPlace)
Sep-20-19 09:01AM	Pelosi says she hopes for Trumps support as she unveils plan to lower drug prices (MarketWatch)
Sep-11-19 04:43PM	Potential Peanut Allergy Treatment Gives Pharma Company A Boost (ETF Trends)
Aug-27-19 10:05AM	Amgen to Buy Celgene's Otezla: 5 ETF Drugs (Zacks)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jul-24-19 12:15PM	7 Bad ETFs That Just Arent Worth the Trouble This Year (InvestorPlace)
Jul-14-19 11:00AM	4 Hot Pharmaceutical ETFs (ETF Trends)
Jul-09-19 04:18PM	Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump (Investor's Business Daily)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
06:01PM	Loading…
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Apr-09-19 02:14PM	4 ETFs to Consider with Big Pharma on the Senates Hot Seat (ETF Trends)
Mar-08-19 08:00AM	4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run (Zacks)
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday (Zacks)
Feb-28-19 04:43PM	Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results (ETF Trends)
Feb-21-19 10:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 09:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-07-19 09:27AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-04-19 10:01AM	Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus (Zacks)
Dec-14-18 09:28AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-22-18 03:30PM	ETF Plays for a Divided Midterm Elections (ETF Trends)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Oct-09-18 11:39AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Sep-06-18 04:56PM	Pharmaceutical ETFs Could Maintain Their Momentum (ETF Trends)
Aug-12-18 04:56AM	Is Projprzem SAs (WSE:PJP) Balance Sheet Strong Enough To Weather A Storm? (Simply Wall St.)
Aug-02-18 10:47AM	5 Strong Healthcare ETFs to Buy (InvestorPlace)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-11-18 03:23PM	Best Sector ETFs of Last Week (Zacks)
Jun-08-18 04:01PM	Play the Best Sector of Summer With These ETFs & Stocks (Zacks)
May-18-18 08:15AM	Who Are Projprzem SA.s (WSE:PJP) Major Shareholders? (Simply Wall St.)
May-11-18 04:18PM	6 Top Healthcare ETFs Rally as Trump Vows End to Global Freeloading (ETF Trends)
May-10-18 11:03AM	Does Projprzem SA.s (WSE:PJP) PE Ratio Signal A Buying Opportunity? (Simply Wall St.)
Apr-24-18 06:41AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Apr-20-18 12:38PM	Projprzem SA. (WSE:PJP) Delivered A Better ROE Than The Industry, Heres Why (Simply Wall St.)
Apr-13-18 09:15AM	Is Projprzem SA. (WSE:PJP) A Financially Sound Company? (Simply Wall St.)
Mar-24-18 10:47AM	How to Invest in Healthcare Stocks the Easy Way (Motley Fool)
Jan-23-18 01:12PM	Vermont Legalizes Recreational Marijuana on January 22, 2018 (Market Realist)
Jan-18-18 10:30AM	A Look into Amgens Collaborations in 2H17 (Market Realist)
Nov-22-17 10:31AM	Mercks Immunology and Oncology Drugs, Post-3Q17 (Market Realist)
Nov-13-17 03:03PM	What Led to the Rise in the US Trade Deficit in September? (Market Realist)
Oct-30-17 12:25PM	Top 3 Pharmaceutical ETFs of 2017 (Investopedia)
Sep-12-17 07:37AM	How Mercks Diabetes Portfolio Performed in 2Q17 (Market Realist)
Sep-08-17 07:37AM	Why Jazz Pharmaceuticals Vyxeos Could Boost Revenue Growth in 2018 (Market Realist)
Sep-05-17 09:06AM	Eli Lilly & Co.s Recent Developments after Its 2Q17 Earnings (Market Realist)
Sep-01-17 10:37AM	Performance of Eli Lillys Endocrine Franchise in 2Q17 (Market Realist)
10:36AM	How Pfizers Enbrel and Xeljanz Are Positioned after 2Q17 (Market Realist)
07:36AM	Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders (Market Realist)
07:36AM	A Post-2Q17 Look at Pfizers Internal Medicines (Market Realist)
Aug-31-17 01:39PM	Why $475,000 isn't actually that expensive for Novartis's new drug (Yahoo Finance)
01:05PM	Why a $475,000 drug price tag isn't expensive (Yahoo Finance Video)
07:36AM	Bristol-Myers Squibbs Immunoscience Products in 2Q17 (Market Realist)
Aug-30-17 02:27PM	Trump can lower U.S. drug prices by fixing NAFTA (Yahoo Finance)
Aug-28-17 09:06AM	A Look into Mercks Immunology and Oncology Portfolio (Market Realist)
Aug-23-17 11:54AM	What Jazz Pharmaceuticals Expects for Vyxeos (Market Realist)
Aug-22-17 09:07AM	How Allergans US Specialized Therapeutics Segment Performed in 2Q17 (Market Realist)
07:37AM	Behind Xyrems Solid Demand Trends in 2017 (Market Realist)
07:36AM	Eliquis and Sprycel Could Boost BMYs Revenue Growth in 2H17 (Market Realist)
Aug-17-17 07:36AM	How Amgens Nephrology Drugs Are Positioned after 2Q17? (Market Realist)
Aug-10-17 10:36AM	Celgenes Abraxane Continued Steady Growth in 2Q17 (Market Realist)
Aug-07-17 09:45AM	Q2 Earnings Fail to Impress Pharma ETF (Zacks)
Aug-04-17 01:57PM	Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does (InvestorPlace)
Aug-01-17 10:41AM	How Gilead Sciences HCV Franchise Is Positioned after 2Q17 (Market Realist)
09:09AM	Dupixent Could Substantially Drive Regenerons Growth (Market Realist)
Jul-31-17 04:36PM	Examining Bristol-Myers Squibbs Oncology Portfolios 2Q17 (Market Realist)
07:40AM	Eli Lilly in 2Q17: Humulin and Endocrine Products (Market Realist)
Jul-28-17 07:36AM	Behind Pfizers Legacy Established Products Performance in 2017 (Market Realist)
Jul-14-17 10:37AM	Behind Allergans Business Segments and Revenues (Market Realist)
Jul-10-17 03:10PM	What Lies Ahead for Pharma ETFs in Second Half 2017 (Zacks)
10:37AM	How Bristol-Myers Squibb Stock Has Performed in 2Q17 (Market Realist)
Jul-07-17 12:00PM	Improving Health for This Pharma ETF (Investopedia)
Jul-05-17 09:06AM	Johnson & Johnsons Consumer Business in 1Q17 (Market Realist)
Jul-03-17 12:25PM	Gordon Gekko was right: Stocks are now a zero-sum game (Yahoo Finance)
10:37AM	How Did Keytruda Perform in 1Q17? (Market Realist)
Jun-30-17 01:44PM	Why the US is losing the war on drug prices: trader (Yahoo Finance)
11:37AM	Stocks edge up as Q2 draws to a close (Yahoo Finance)
Jun-29-17 08:00AM	Trending: OPEC Fails to Scare Oil Short-Sellers (ETF Database)

Invesco Dynamic Pharmaceuticals ETF seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

open in screener | open in yahoo | open in marketwatch | open in google

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MNST

Monster Beverage Corp.

PJP

Invesco Pharmaceuticals ETF

Upgrade your FINVIZ experience